Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04451382 · ClinicalTrials.gov registry record
PTNS vs Botox of Refractory OAB
A clinical trial, sponsored by Medstar Health Research Institute.
- Terminated
- Registry status
- 150
- Enrollment target
NCT04451382 is a clinical trial that was terminated before completion, run by Medstar Health Research Institute. The registered enrollment target is 150 participants.
The verdict
NCT04451382 was terminated before completion, sponsored by Medstar Health Research Institute.
- TERMINATED
- Registry status
- 150 participants
- Enrollment target
Study Summary
This is a prospective cohort study of women with overactive bladder OAB (dry or wet) who have failed 2 prior treatments, including behavioral modification, pelvic floor physical therapy, and/or OAB medication (anticholinergics or mirabegron), and have chosen either OnabotulinumtoxinA (BTX) injection or percutaneous tibial nerve stimulation (PTNS) as their next treatment. OAB-dry refers to patients with OAB who do not have urge urinary incontinence; OAB-wet refers to patients with OAB and urge urinary incontinence. Eligible patients will be approached for study participation after they have decided to proceed with BTX or PTNS.
Interventions
- BIOLOGICAL OnabotulinumtoxinA (BoNTA)
- PROCEDURE Percutaneous tibial nerve stimulation (PTNS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2015-03 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04451382
The ClinicalTrials.gov registry entry for NCT04451382 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which OnabotulinumtoxinA (BoNTA) is the first listed.
NCT04451382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04451382 about?
NCT04451382 is a clinical study titled "PTNS vs Botox of Refractory OAB". This is a prospective cohort study of women with overactive bladder OAB (dry or wet) who have failed 2 prior treatments, including behavioral modification, pelvic floor physical therapy, and/or OAB medication (anticholinergics or mirabegron), and have chosen either OnabotulinumtoxinA (BTX) injection...
What is the current status of trial NCT04451382?
This trial is currently terminated. The enrollment target is 150 participants. The study started on 2015-03. Estimated completion is 2018-12.
What interventions are being tested in trial NCT04451382?
The interventions under investigation include: OnabotulinumtoxinA (BoNTA) (BIOLOGICAL), Percutaneous tibial nerve stimulation (PTNS) (PROCEDURE).
Who is sponsoring clinical trial NCT04451382?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.